Jul 22, 2024
QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs
QDX, a computational drug discovery company, today announced a collaboration with Prelude Therapeutics, a clinical-stage precision oncology company, targeting undisclosed, previously undrugged oncology targets.